Headline News

CHICAGO — Survivors of an acute MI reported fear of a recurrence up to 8 months later, along with high levels of perceived stress that were distinct from depression and anxiety symptoms, researchers reported.

BOSTON — Daily tapinarof cream 1% improved weekly itch outcomes and sleep in patients with atopic dermatitis and pruritus, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

CMS and HHS finalized a federal rule aimed at increasing the number of kidney transplants and addressing disparities among potential organ recipients, according to a CMS press release.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.

A proof-of-concept trial revealed that GA2, a second-generation vaccine candidate that uses genetically attenuated malaria parasites, prevented 89% of participants who received it from being infected with malaria.

BOSTON — Patients with hereditary angioedema may down-titrate lanadelumab treatment while exhibiting symptom control, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Receiving a benralizumab injection during an acute asthma or COPD exacerbation with a blood eosinophil count of at least 300 cells/µL led to fewertreatment failures, according to results published in The Lancet Respiratory Medicine.

Healio has compiled the most-read news in pulmonology posted in November.

Baseline concomitant exposure to commonly used medications, such as corticosteroids and 5-aminosalicylates, did not significantly affect clinical and endoscopic outcomes during induction therapy in ulcerative colitis, data analysis showed.

WASHINGTON — Healio spoke with Jeffrey A. Sparks, MD, MMSc, about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.